ID

16056

Beschrijving

Documentation part: Status of Treatment Bling & Study Conclusion A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Trefwoorden

Versies (1)
  1. 27-06-16 27-06-16 -
Geüploaded op

27 juni 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Engels

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulieren  
Status of Treatment Blind (BLIND)
Beschrijving

Status of Treatment Blind (BLIND)

Was the treatment blind broken during the study?
Beschrijving

If yes, complete the Adverse Event form and/or Investigational Product forms as appropriate

Datatype

text

Alias
UMLS CUI [1]
C2347038
Date blind broken
Beschrijving

Date blind broken

Datatype

date

Maateenheden
  • DDMONYYYY
Alias
UMLS CUI [1]
C0011008
DDMONYYYY
Reason blind broken
Beschrijving

Reason blind broken

Datatype

text

Alias
UMLS CUI [1]
C0392360
If "Other", please specify:
Beschrijving

If

Datatype

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Study Conclusion (CONC)
Beschrijving

Study Conclusion (CONC)

Date of subject completion or date of subject withdrawal
Beschrijving

Date of subject completion or date of subject withdrawal

Datatype

date

Alias
UMLS CUI [1]
C2983670
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0422727
Was the subject withdrawn from the study?
Beschrijving

Was the subject withdrawn from the study?

Datatype

text

Alias
UMLS CUI [1]
C0422727
If "Yes", select primary reason for withdrawal
Beschrijving

If "Yes", select primary reason for withdrawal

Datatype

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0422727
If "other", specify:
Beschrijving

If "other", specify:

Datatype

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0205394
Terug naar het begin van de pagina

Similar models

Status of Treatment Bling & Study Conclusion Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Status of Treatment Blind (BLIND)
Item
Was the treatment blind broken during the study?
text
C2347038 (UMLS CUI [1])
Was the treatment blind broken during the study?
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes (Y)
Date blind broken
Item
Date blind broken
date
C0011008 (UMLS CUI [1])
Item
Reason blind broken
text
C0392360 (UMLS CUI [1])
Reason blind broken
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other (2)
If
Item
If "Other", please specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Study Conclusion (CONC)
Date of subject completion or date of subject withdrawal
Item
Date of subject completion or date of subject withdrawal
date
C2983670 (UMLS CUI [1])
C0011008 (UMLS CUI [2,1])
C0422727 (UMLS CUI [2,2])
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Was the subject withdrawn from the study?
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
If "Yes", select primary reason for withdrawal
text
C0392360 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
If "Yes", select primary reason for withdrawal
Code List
If "Yes", select primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Disease progression (7)
CL Item
Other (OT)
If "other", specify:
Item
If "other", specify:
text
C0392360 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial